skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Advanced Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Primo Advanced Search Query Term
Input search text:
Show Results with:
criteria input
Qualquer
Show Results with:
Qualquer
Primo Advanced Search prefilters
Tipo de material:
criteria input
Todos os itens
Busca Geral
Busca Simples
This feature requires javascript
Human recombinant erythropoietin therapy
Donato, Hugo ;
Ferro
, Hugo
Medicina (Buenos Aires), 2006, Vol.66 (1), p.51
[Periódico revisado por pares]
Argentina
Texto completo disponível
Citações
Citado por
Exibir Online
Detalhes
Resenhas & Tags
Mais Opções
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Human recombinant erythropoietin therapy
Autor:
Donato, Hugo
;
Ferro
, Hugo
Assuntos:
Adult
;
Anemia - drug therapy
;
Anemia - etiology
;
Anemia, Neonatal - drug therapy
;
Child
;
Child, Preschool
;
Erythropoietin - adverse effects
;
Erythropoietin - therapeutic use
;
Hepatitis C - drug therapy
;
HIV Infections - complications
;
Humans
;
Infant
;
Infant, Newborn
;
Infant, Postmature
;
Neoplasms - complications
;
Recombinant Proteins
;
Renal Dialysis
;
Renal Insufficiency - complications
;
Renal Insufficiency - drug therapy
É parte de:
Medicina (Buenos Aires), 2006, Vol.66 (1), p.51
Descrição:
Recombinant human erythropoietin (rHuEpo) has become the most widely used cytokine in the world. Following the success of its use in patients with end-stage renal disease, the usefulness of rHuEpo to ameliorate other anemias was assessed, including pediatric patients and newborn infants. The treatment or prevention of anemia of prematurity with rHuEpo resulted in a significant reduction in the number of transfusions and donor exposure. A clear definition of which premature babies must receive therapy needs yet to be established. Other indications in neonatal period include hyporegenerative and hemolytic anemias. With the exception of chronic renal failure, in older children the efficacy of rHuEpo has not been evaluated as in adults. While an impressive amount of studies were carried out during the last years in adult patients with cancer-related or HIV-infection-related anemias, allowing to establish clear conclusions on its efficacy, only a few trials with small number of patients have been reported in children. Up to date, results in pediatric patients suggest that rHuEpo therapy is as useful as in adult patients, but prospective, randomized trials including large number of patients are essential to achieve definitive conclusions. Results of studies designed to evaluate the efficacy of rHuEpo for sustaining an adequate dose of ribavirin in patients receiving treatment for hepatitis C are encouraging. The potential for use of the non-hematopoietic effects of rHuEpo in newborn infants is a novel and exciting issue. The role of rHuEpo as a tissue protective factor for central nervous system and intestinal mucosa is under exhaustive investigation.
Editor:
Argentina
Idioma:
Espanhol
Links
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
Anterior
Resultado
10
Avançar
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript